Complication | Evidence | PMID |
Nephropathy | 1. Genetic variants in angiotensin-converting enzyme (ACE), tumor necrosis factor-alpha (TNF-alpha) and erythropoietin (EPO) have been associated with diabetic nephropathy. | 25656761 |
Cardiovascular | 1. ACE inhibition reduces the development of diabetes, improves these surrogate markers, and reduces cardiovascular disease and renal disease. | 12818733 |
Retinopathy | 1. We conclude that ACE levels are elevated in type II diabetes, chiefly in patients with retinopathy. This finding may reflect microvascular damage caused by secretion of ACE by the vascular endothelial cells. | 2157294 |
Neuropathy | 1. The presence of the D allele is associated with increased risk of peripheral neuropathy in females but not in male subjects with type 2 DM, suggesting a role for the renin-angiotensin system in the development of peripheral neuropathy (PN). | 16949519 |
Insulin resistance and inflammation | 1. CONCLUSION: Our data suggest that VPP inhibits adipose inflammation in the interaction between adipocytes and macrophages, acting as an ACE inhibitor, thereby improving obesity-related insulin resistance. | 26346532 |